UBS Group
QGENF

UBS Group’s QIAGEN NV QGENF Stock Holding History

UBS Group’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-302,759
Closed -$8.48M – 8504
2016
Q4 		$8.48M Buy
302,759
+223,751
+283% +$6.27M ﹤0.01% 1648
2016
Q3 		$2.17M Sell
79,008
-113,720
-59% -$3.12M ﹤0.01% 2762
2016
Q2 		$4.2M Buy
192,728
+30,416
+19% +$663K ﹤0.01% 2097
2016
Q1 		$3.63M Sell
162,312
-43,658
-21% -$975K ﹤0.01% 2149
2015
Q4 		$5.7M Buy
205,970
+47,490
+30% +$1.31M ﹤0.01% 1843
2015
Q3 		$4.09M Sell
158,480
-41,110
-21% -$1.06M ﹤0.01% 2085
2015
Q2 		$4.95M Buy
199,590
+14,874
+8% +$369K ﹤0.01% 2095
2015
Q1 		$4.65M Buy
184,716
+34,978
+23% +$881K ﹤0.01% 2133
2014
Q4 		$3.51M Buy
+149,738
New +$3.51M ﹤0.01% 2384

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

UBS Group's QGENF Position: Q1 2017 in Review

UBS Group sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 302,759 shares — an estimated $8.48M sold.

UBS Group first reported a position in QGENF in Q4 2014 and held it in 9 quarters. The position peaked at $8.48M in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • UBS Group reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • UBS Group sold 302,759 QIAGEN NV shares in Q1 2017, an estimated $8.48M.
  • UBS Group first reported a position in QIAGEN NV in Q4 2014 and held it in 9 quarters.
  • UBS Group's QIAGEN NV position peaked at $8.48M in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.